InVivo Therapeutics Holdings Corp. (NVIV) Reports Positive Results of New Spinal Cord Injury Treatment on Rodents
InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that preliminary data revealed that their proprietary biopolymer scaffold implant demonstrated positive therapeutic results with rodents. Following the implementation of the Company's technology in an acute SCI model, the data showed evidence of decreased scarring, decreased lesion size, and increased neural survival. These results reinforce previous positive data from Invivo's findings in hemisection models in both rodents and non-human primates. The major cause of SCI is motor vehicle accidents, sports-related accidents and falls. Most of the currently…